Novo Nordisk’s Wegovy and copyright, both equally driven by semaglutide, have revolutionized being overweight cure by unparalleled weight loss effects.California biotech behemoth Amgen ditched options for an experimental weight loss tablet in May but remains to be hoping for a slice of the market with MariTide, a month-to-month injection that may